ALVIO.PA
Valerio Therapeutics SA
Price:  
0.07 
EUR
Volume:  
24,213.00
France | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ALVIO.PA WACC - Weighted Average Cost of Capital

The WACC of Valerio Therapeutics SA (ALVIO.PA) is 7.9%.

The Cost of Equity of Valerio Therapeutics SA (ALVIO.PA) is 10.45%.
The Cost of Debt of Valerio Therapeutics SA (ALVIO.PA) is 5.00%.

Range Selected
Cost of equity 8.80% - 12.10% 10.45%
Tax rate 1.60% - 3.60% 2.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 7.0% - 8.8% 7.9%
WACC

ALVIO.PA WACC calculation

Category Low High
Long-term bond rate 3.0% 3.5%
Equity market risk premium 5.8% 6.8%
Adjusted beta 0.99 1.19
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.80% 12.10%
Tax rate 1.60% 3.60%
Debt/Equity ratio 0.82 0.82
Cost of debt 5.00% 5.00%
After-tax WACC 7.0% 8.8%
Selected WACC 7.9%